Human monocyte CD14 is upregulated by lipopolysaccharide.

Infection and Immunity
R LandmannW Zimmerli

Abstract

Membrane CD14 is involved in lipopolysaccharide (LPS)-induced monocyte activation; it binds LPS, and antibodies against CD14 block the effects of low-dose LPS. It is unknown how LPS regulates its own receptor CD14 in vitro. Therefore, we investigated the effects of LPS on CD14 mRNA and membrane and soluble CD14 (mCD14 and sCD14, respectively) in human monocytes and macrophages. No changes were observed during the first 3 h of LPS stimulation. After 6 to 15 h, LPS weakly reduced CD14 mRNA and mCD14 and transiently enhanced sCD14 release. A 2-day incubation with LPS caused increases in the levels of CD14 mRNA (2-fold), mCD14 (2-fold), sCD14 (1.5-fold), and LPS-fluorescein isothiocyanate binding (1.5-fold); a 5-h incubation with LPS was sufficient to induce the late effects on mCD14 and sCD14. The maximal effect on mCD14 and sCD14 was reached with > or = 1 ng of LPS per ml; the proportional distribution of the two sCD14 isoforms was not modified by LPS. Besides rough and smooth LPS, lipid A, heat-killed Escherichia coli, lipoteichoic acid, and Staphylococcus aureus cell wall extract (10 micrograms/ml) caused similar increases of mCD14. The LPS effect was blocked by polymyxin B but not by anti-tumor necrosis factor alpha, anti-inte...Continue Reading

References

Dec 1, 1992·The Journal of Experimental Medicine·E A FreyS D Wright
Jun 1, 1992·European Journal of Immunology·A MarchantM Goldman
May 31, 1991·Science·C R Maliszewski
Jan 15, 1991·Biochemical and Biophysical Research Communications·L E DeForge, D G Remick
Sep 21, 1990·Science·R R SchumannR J Ulevitch
May 1, 1994·The Journal of Experimental Medicine·K MatsuuraS Yamamoto
Mar 1, 1995·The Journal of Experimental Medicine·C FearnsD J Loskutoff
Mar 1, 1995·The Journal of Infectious Diseases·R LandmannT Calandra
Sep 1, 1994·Immunity·J PuginR J Ulevitch
Jan 1, 1995·Annual Review of Immunology·R J Ulevitch, P S Tobias
Jan 1, 1994·Journal of Leukocyte Biology·H W Ziegler-HeitbrockJ G Haas

❮ Previous
Next ❯

Citations

Nov 1, 1996·European Journal of Immunology·T TakakuwaM A Freudenberg
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C R GardnerD L Laskin
Feb 14, 2002·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·J KarhukorpiR Karttunen
May 3, 2002·Clinical and Experimental Immunology·J KarhukorpiR Karttunen
Sep 23, 2003·Current Opinion in Allergy and Clinical Immunology·Gerard H Koppelman, Dirkje S Postma
Apr 14, 2010·Scandinavian Journal of Immunology·P JuliusJ C Virchow
Jul 17, 2010·Journal of Cellular Physiology·Eva FreisingerReza Izadpanah
Nov 13, 2013·Expert Review of Clinical Immunology·Kirsten Glaser, Christian P Speer
Jun 24, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Rafael Fernandez-BotranJose Bordon
Jul 25, 2014·The Journal of Infectious Diseases·Duy M DinhHonorine D Ward
Jan 28, 2016·PLoS Neglected Tropical Diseases·Priscila L Dos SantosRoque P de Almeida
Jan 1, 2017·The Journal of Biological Chemistry·Claudia LentucciValentina Perissi
May 29, 2018·Expert Review of Gastroenterology & Hepatology·Francesca Romana PonzianiMaurizio Pompili
Apr 9, 2020·Frontiers in Immunology·Prathapan AyyappanNora E Sarvetnick
Aug 23, 2020·Journal of Clinical Medicine·Agostino Di CiaulaPiero Portincasa
Apr 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H A JärveläinenK O Lindros
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jin-Hwa LeeHaibo Zhang
Apr 3, 2004·American Journal of Respiratory Cell and Molecular Biology·Shu-Min LinThomas R Martin
Jun 9, 2004·European Journal of Heart Failure·Viviane M ConraadsChristiaan J Vrints
Apr 30, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Paola BrunDiego Martines
Feb 26, 2008·FEMS Immunology and Medical Microbiology·Tigran K DavtyanSamvel A Avetisyan
Jan 22, 2011·The Journal of Infectious Diseases·Netanya G SandlerUNKNOWN INSIGHT SMART Study Group
May 2, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Odile Poulain-GodefroyPhilippe Froguel
Jun 19, 2012·Clinical Reviews in Allergy & Immunology·Godfrey Chi-Fung ChanDaniel Man-Yuen Sze
Feb 22, 2012·European Journal of Microbiology & Immunology·O CohavyS R Targan
Nov 22, 2012·AIDS·Morgan A MarksAnil K Chaturvedi
Jun 4, 2014·PloS One·Vania Sammartino MarianoMaria Cristina Roque-Barreira
Oct 15, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Richard M DunhamJoseph M McCune
Jan 1, 1998·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals· Jillian R M Swan Andrew D Curran Paul N Beckett
Nov 2, 2014·Cellular Microbiology·Peter M MerrittMelanie M Marketon
Nov 1, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Danai AgiasotelliSpyros P Dourakis
Aug 18, 2016·The American Journal of Drug and Alcohol Abuse·Mollie A Monnig
Oct 14, 2017·Current Opinion in HIV and AIDS·Sandra Pinto-CardosoGustavo Reyes-Terán
Aug 1, 1997·The Journal of Veterinary Medical Science·A IkedaK Sekikawa
Jan 29, 2000·European Journal of Clinical Investigation·P Antal-Szalmás
Oct 21, 2005·Journal of Neuroscience Research·Ya-Fen Jiang-ShiehChing-Hsiang Wu
Jan 1, 2008·Proteomics. Clinical Applications·Angus BrownCristobal Dos Remedios

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.